KMT2A and acute leukemia: Fusion genes have been identified as specific molecular markers of acute leukemia, and PTPN11 mutations have been observed to co-exist with MLL-AML (MLL-AF6, MLL-AF10) and CBFβ-MYH11, which is in accordance with previously reported findings in the literature [43,44].